Abstract
Alzheimer's disease (AD) is characterized mainly by the accumulation of aggregates of beta-amyloid peptide (bA) in the patient's brain that lead to severe synaptic and cognitive dysfunctions not available in neurodegenerative dementia. Several studies indicate that bA toxicity comes from the process of aggregation and interaction with a neuronal membrane. Other studies suggest that non-am…